Cisapride monohydrate (BioDeep_00000839636)

   


代谢物信息卡片


Cisapride monohydrate

化学式: C23H31ClFN3O5 (483.19361580000003)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F.O
InChI: 1H2

描述信息

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

同义名列表

1 个代谢物同义名

Cisapride monohydrate



数据库引用编号

5 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Erica R Feldman, Bhupinder Singh, Noah G Mishkin, Erica R Lachenauer, Manuel Martin-Flores, Erin K Daugherity. Effects of Cisapride, Buprenorphine, and Their Combination on Gastrointestinal Transit in New Zealand White Rabbits. Journal of the American Association for Laboratory Animal Science : JAALAS. 2021 03; 60(2):221-228. doi: 10.30802/aalas-jaalas-20-000064. [PMID: 33632373]
  • Sonia Goineau, Vincent Castagné. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers. Journal of pharmacological and toxicological methods. 2018 Mar; 90(?):58-66. doi: 10.1016/j.vascn.2017.12.003. [PMID: 29274391]
  • S M Ghoreishi, M Nouri, A Rasooli, M Ghorbanpour, M R Mokhber-Dezfouli, P D Constable. Effect of orally administered cisapride, bethanechol, and erythromycin on the apparent efficiency of colostral IgG absorption in neonatal Holstein-Friesian calves. Journal of veterinary internal medicine. 2015 Mar; 29(2):714-20. doi: 10.1111/jvim.12539. [PMID: 25641234]
  • Ping Liang, Feng Lan, Andrew S Lee, Tingyu Gong, Veronica Sanchez-Freire, Yongming Wang, Sebastian Diecke, Karim Sallam, Joshua W Knowles, Paul J Wang, Patricia K Nguyen, Donald M Bers, Robert C Robbins, Joseph C Wu. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation. 2013 Apr; 127(16):1677-91. doi: 10.1161/circulationaha.113.001883. [PMID: 23519760]
  • Myung-Jae Lee, Heon-Woo Lee, Jong-Min Kang, Ji-Hyung Seo, Seong-Kun Tak, Wangseob Shim, Sung-Vin Yim, Seung Jae Hong, Kyung-Tae Lee. Application of a rapid and selective method for the simultaneous determination of carebastine and pseudoephedrine in human plasma by liquid chromatography-electrospray mass spectrometry for bioequivalence study in Korean subjects. Biomedical chromatography : BMC. 2010 Oct; 24(10):1031-7. doi: 10.1002/bmc.1392. [PMID: 20099369]
  • Michael Margulis, Steve Sorota, Inhou Chu, Anthony Soares, Tony Priestley, Amin A Nomeir. Protein binding-dependent decreases in hERG channel blocker potency assessed by whole-cell voltage clamp in serum. Journal of cardiovascular pharmacology. 2010 Apr; 55(4):368-76. doi: 10.1097/fjc.0b013e3181d2ce39. [PMID: 20125032]
  • Guillermo Alberto Keller, Guillermo Di Girolamo. Prokinetic agents and QT prolongation: a familiar scene with new actors. Current drug safety. 2010 Jan; 5(1):73-8. doi: 10.2174/157488610789869166. [PMID: 20210722]
  • Mitsuyasu Tabo, Ryuichi Komatsu, Masaki Honda, Misae Itoh, Kazuya Kimura. Cardiovascular safety profile of MA-2029, a novel motilin receptor antagonist. The Journal of toxicological sciences. 2008 Dec; 33(5):631-9. doi: 10.2131/jts.33.631. [PMID: 19043284]
  • J A M Smith, D T Beattie, D Marquess, J P Shaw, R G Vickery, P P A Humphrey. The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity. Naunyn-Schmiedeberg's archives of pharmacology. 2008 Jul; 378(1):125-37. doi: 10.1007/s00210-008-0282-y. [PMID: 18415081]
  • Hye Young Ji, Eun Jeong Park, Kang Choon Lee, Hye Suk Lee. Quantification of doxazosin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. Journal of separation science. 2008 May; 31(9):1628-33. doi: 10.1002/jssc.200700662. [PMID: 18401863]
  • Anna Ollerstam, Sandra A G Visser, Göran Duker, Tomas Forsberg, Anna H Persson, Lars B Nilsson, Jan-Arne Björkman, Johan Gabrielsson, Ahmad Al-Saffar. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. Journal of pharmacological and toxicological methods. 2007 Sep; 56(2):131-44. doi: 10.1016/j.vascn.2007.05.002. [PMID: 17689270]
  • Kazuya Kimura, Mitsuyasu Tabo, Misae Itoh, Keiji Mizoguchi, Atsuhiko Kato, Masami Suzuki, Zen Itoh, Satoshi Omura, Hisanori Takanashi. Preclinical electrophysiology assays of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin. The Journal of toxicological sciences. 2007 Aug; 32(3):217-30. doi: 10.2131/jts.32.217. [PMID: 17785939]
  • James T Limberis, Jeff S McDermott, Heinz J Salmen, Zhi Su, Ann Mikhail, Jonathon R Green, Bryan F Cox, Gary A Gintant, Ruth L Martin. The effects of plasma proteins on delayed repolarization in vitro with cisapride, risperidone, and D, L-sotalol. Journal of pharmacological and toxicological methods. 2007 Jul; 56(1):11-7. doi: 10.1016/j.vascn.2007.01.001. [PMID: 17350293]
  • Anna Ollerstam, Anna H Persson, Sandra A G Visser, J Magnus Fredriksson, Tomas Forsberg, Lars B Nilsson, Göran Eklund, Stig Johan Wiklund, Johan Gabrielsson, Göran Duker, Ahmad Al-Saffar. A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog. Journal of pharmacological and toxicological methods. 2007 Jan; 55(1):35-48. doi: 10.1016/j.vascn.2006.02.009. [PMID: 16581270]
  • Alberto P Madeiro, Andréa C Rufino, Marair G F Sartori, Edmund C Baracat, Geraldo Rodrigues De Lima, Manoel J B C Girão. The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study. International urogynecology journal and pelvic floor dysfunction. 2006 May; 17(3):248-52. doi: 10.1007/s00192-005-1318-1. [PMID: 15959612]
  • Jun Guo, Hongying Gang, Shetuan Zhang. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels. The Journal of pharmacology and experimental therapeutics. 2006 May; 317(2):865-74. doi: 10.1124/jpet.105.098103. [PMID: 16397089]
  • J R E Fraser, P R Gibson. Mechanisms by which food intake elevates circulating levels of hyaluronan in humans. Journal of internal medicine. 2005 Nov; 258(5):460-6. doi: 10.1111/j.1365-2796.2005.01564.x. [PMID: 16238682]
  • Motohiro Shiotani, Takuma Harada, Junko Abe, Yasufusa Sawada, Keitaro Hashimoto, Yoshimasa Hamada, Ikuo Horii. Practical application of guinea pig telemetry system for QT evaluation. The Journal of toxicological sciences. 2005 Aug; 30(3):239-47. doi: 10.2131/jts.30.239. [PMID: 16141657]
  • Jeffrey Alderman. Coadministration of sertraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected QT intervals in healthy adult volunteers. Clinical therapeutics. 2005 Jul; 27(7):1050-63. doi: 10.1016/j.clinthera.2005.07.013. [PMID: 16154484]
  • Juris J Meier, Guido Kemmeries, Jens J Holst, Michael A Nauck. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. Diabetes. 2005 Jul; 54(7):2212-8. doi: 10.2337/diabetes.54.7.2212. [PMID: 15983224]
  • Bimaljit S Sandhu, Rajesh Gupta, Jayant Sharma, Jagdeep Singh, Nandagudi S Murthy, Shiv K Sarin. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. Journal of gastroenterology and hepatology. 2005 Apr; 20(4):599-605. doi: 10.1111/j.1440-1746.2005.03796.x. [PMID: 15836710]
  • Rashmi R Shah. Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules. Expert opinion on drug safety. 2005 Jan; 4(1):103-28. doi: 10.1517/14740338.4.1.103. [PMID: 15709902]
  • V H M Deneer, L Lie-A-Huen, J H Kingma, J H Proost, S A Gossen, A Stuurman, G M M Uytdehaag, P H J M Dunselman, J R B J Brouwers. Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation. European journal of clinical pharmacology. 2004 Dec; 60(10):693-701. doi: 10.1007/s00228-004-0831-3. [PMID: 15619132]
  • V L Hegde, Y P Venkatesh. Anaphylaxis to excipient mannitol: evidence for an immunoglobulin E-mediated mechanism. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2004 Oct; 34(10):1602-9. doi: 10.1111/j.1365-2222.2004.02079.x. [PMID: 15479277]
  • Y Reznik, H Lefebvre, V Rohmer, B Charbonnel, A Tabarin, P Rodien, P Lecomte, S Bardet, C Coffin, J Mahoudeau. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clinical endocrinology. 2004 Sep; 61(3):311-9. doi: 10.1111/j.1365-2265.2004.02048.x. [PMID: 15355446]
  • Shigeru Furuta, Emiko Kamada, Takeshi Omata, Tohru Sugimoto, Yoshihiro Kawabata, Keiko Yonezawa, Xiaochun Cheryl Wu, Tadashi Kurimoto. Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338. European journal of pharmacology. 2004 Aug; 497(2):223-31. doi: 10.1016/j.ejphar.2004.06.040. [PMID: 15306208]
  • L G Hare, D S Mitchel, J S Millership, P S Collier, J C McElnay, M D Shields, D J Carson, R Fair. Liquid chromatographic determination including simultaneous "on-cartridge" separation of ranitidine cisapride drug combinations from paediatric plasma samples using an automated solid-phase extraction procedure. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2004 Jul; 806(2):263-9. doi: 10.1016/j.jchromb.2004.04.007. [PMID: 15171937]
  • Ender Tekes, Banu Bayar, Selda Emre-Aydingoz, Meral Tuncer. Mechanism of action of the cisapride-induced vasodilatation in renal vasculature of rat. The Indian journal of medical research. 2004 Mar; 119(3):115-20. doi: . [PMID: 15115163]
  • J Emami, J Varshosaz, M Falamarzian, R Tahvilian. High performance liquid chromatographic determination, pharmacokinetic and comparative bioavailability studies of cisapride. Journal of pharmaceutical and biomedical analysis. 2003 Oct; 33(3):513-20. doi: 10.1016/s0731-7085(03)00299-1. [PMID: 14550869]
  • Massimo Mannelli, Pietro Ferruzzi, Paola Luciani, Clara Crescioli, Lisa Buci, Giovanni Corona, Mario Serio, Alessandro Peri. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. The Journal of clinical endocrinology and metabolism. 2003 Oct; 88(10):4616-22. doi: 10.1210/jc.2002-021949. [PMID: 14557431]
  • Gregory L Kearns, Patricia K Robinson, John T Wilson, Deanna Wilson-Costello, Gail R Knight, Robert M Ward, John N van den Anker. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny. Clinical pharmacology and therapeutics. 2003 Oct; 74(4):312-25. doi: 10.1016/s0009-9236(03)00225-x. [PMID: 14534518]
  • Filip Cools, Avram Benatar, Els Bruneel, Claire Theyskens, Adel Bougatef, Ann Casteels, Yvan Vandenplas. A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants. European journal of clinical pharmacology. 2003 May; 59(1):17-22. doi: 10.1007/s00228-003-0582-6. [PMID: 12682804]
  • James D Lillich, Peter C Rakestraw, Allen J Roussel, Melissa R Finley, Suhasini Ganta, Lisa C Freeman. Expression of the ether-a-go-go (ERG) potassium channel in smooth muscle of the equine gastrointestinal tract and influence on activity of jejunal smooth muscle. American journal of veterinary research. 2003 Mar; 64(3):267-72. doi: 10.2460/ajvr.2003.64.267. [PMID: 12661864]
  • Jennifer A Lowry, Gregory L Kearns, Susan M Abdel-Rahman, Anne N Nafziger, Irim S Khan, Angela D M Kashuba, Erin G Schuetz, Joseph S Bertino, John N van den Anker, J Steven Leeder. Cisapride: a potential model substrate to assess cytochrome P4503A4 activity in vivo. Clinical pharmacology and therapeutics. 2003 Mar; 73(3):209-22. doi: 10.1067/mcp.2003.29. [PMID: 12621386]
  • V Contesse, Y Reznik, C Duparc, V Perraudin, H Vaudry, J M Kuhn, H Lefebvre. Effects of serotonin and vasopressin on cortisol production from an adrenocortical tumor causing subclinical Cushing's syndrome. Endocrine research. 2002 Nov; 28(4):787-91. doi: 10.1081/erc-120017074. [PMID: 12530699]
  • F Odoul, C Le Guellec, A Henrot, E Saliba, J C Levron, M C Saux, G Paintaud, E Autret-Leca. Population pharmacokinetics of cisapride in neonates. European journal of clinical pharmacology. 2002 Nov; 58(8):507-13. doi: 10.1007/s00228-002-0504-z. [PMID: 12451427]
  • Matthijs P Schwartz, Melvin Samsom, Willem Renooij, Leo W van Steenderen, Marc A Benninga, Erwin-Jan M van Geenen, Margot A van Herwaarden, Martin B M de Smet, André J P M Smout. Small bowel motility affects glucose absorption in a healthy man. Diabetes care. 2002 Oct; 25(10):1857-61. doi: 10.2337/diacare.25.10.1857. [PMID: 12351491]
  • Anthony A Fossa, Michael J DePasquale, David L Raunig, Michael J Avery, Derek J Leishman. The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment. The Journal of pharmacology and experimental therapeutics. 2002 Aug; 302(2):828-33. doi: 10.1124/jpet.102.035220. [PMID: 12130750]
  • Manfred Marx, Erwin Kitzmueller, Andrea Pichler, Klaus Arbeiter, Christoph Aufricht. Effect of cisapride on rate-corrected QT intervals in children on peritoneal dialysis. Pediatric nephrology (Berlin, Germany). 2002 Aug; 17(8):652-5. doi: 10.1007/s00467-002-0866-6. [PMID: 12185476]
  • Herve Lefebvre, Dorthe Cartier, Celine Duparc, Isabelle Lihrmann, Vincent Contesse, Catherine Delarue, Michel Godin, Rodolphe Fischmeister, Hubert Vaudry, Jean-Marc Kuhn. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. The Journal of clinical endocrinology and metabolism. 2002 Mar; 87(3):1211-6. doi: 10.1210/jcem.87.3.8327. [PMID: 11889190]
  • Eckhard Ficker, Carlos A Obejero-Paz, Shuxia Zhao, Arthur M Brown. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. The Journal of biological chemistry. 2002 Feb; 277(7):4989-98. doi: 10.1074/jbc.m107345200. [PMID: 11741928]
  • Michael Horowitz, Karen L Jones, Philip E Harding, Judith M Wishart. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. Digestion. 2002; 65(1):41-6. doi: 10.1159/000051930. [PMID: 11961342]
  • Caterina Finizia, Lars Lundell, Lars Cange, Magnus Ruth. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease. European journal of gastroenterology & hepatology. 2002 Jan; 14(1):9-14. doi: 10.1097/00042737-200201000-00003. [PMID: 11782569]
  • Avram Benatar, Filip Cools, Tine Decraene, Adel Bougatef, Yvan Vandenplas. The T wave as a marker of dispersion of ventricular repolarization in premature infants before and while on treatment with the I(Kr) channel blocker cisapride. Cardiology in the young. 2002 Jan; 12(1):32-6. doi: 10.1017/s1047951102000069. [PMID: 11922439]
  • R E Pearce, R R Gotschall, G L Kearns, J S Leeder. Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms. Drug metabolism and disposition: the biological fate of chemicals. 2001 Dec; 29(12):1548-54. doi: . [PMID: 11717173]
  • De Beaux, M Chapman, R Fraser, M Finnis, B De Keulenaer, D Liberalli, M Satanek. Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesthesia and intensive care. 2001 Dec; 29(6):619-22. doi: 10.1177/0310057x0102900611. [PMID: 11771607]
  • M J Veysey, P Malcolm, A I Mallet, P J Jenkins, G M Besser, G M Murphy, R H Dowling. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial. Gut. 2001 Dec; 49(6):828-34. doi: 10.1136/gut.49.6.828. [PMID: 11709518]
  • A S Mathis, C Costeas, J A Barone. Retrospective analysis of the effects of cisapride on the QT interval and QT dispersion in chronic hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2001 Dec; 38(6):1284-91. doi: 10.1053/ajkd.2001.29226. [PMID: 11728962]
  • I Bourdeau, P D'Amour, P Hamet, J M Boutin, A Lacroix. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. The Journal of clinical endocrinology and metabolism. 2001 Nov; 86(11):5534-40. doi: 10.1210/jcem.86.11.8062. [PMID: 11701732]
  • R MacLaren, W D Patrick, R I Hall, G M Rocker, G J Whelan, J J Lima. Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults. Clinical therapeutics. 2001 Nov; 23(11):1855-66. doi: 10.1016/s0149-2918(00)89081-5. [PMID: 11768837]
  • J M Tréluyer, E Rey, M Sonnier, G Pons, T Cresteil. Evidence of impaired cisapride metabolism in neonates. British journal of clinical pharmacology. 2001 Oct; 52(4):419-25. doi: 10.1046/j.0306-5251.2001.01470.x. [PMID: 11678785]
  • Z Desta, K T Kivistö, J J Lilja, J T Backman, N Soukhova, P J Neuvonen, D A Flockhart. Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice. British journal of clinical pharmacology. 2001 Oct; 52(4):399-407. doi: 10.1046/j.0306-5251.2001.01473.x. [PMID: 11678783]
  • R K Dhiman, L Arke, A Bhansali, S Gupta, Y K Chawla. Cisapride improves gallbladder emptying in patients with type 2 diabetes mellitus. Journal of gastroenterology and hepatology. 2001 Sep; 16(9):1044-50. doi: 10.1046/j.1440-1746.2001.02586.x. [PMID: 11595071]
  • R Webster, G Allan, K Anto-Awuakye, A Harrison, T Kidd, D Leishman, J Phipps, D Walker. Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog. Xenobiotica; the fate of foreign compounds in biological systems. 2001 Aug; 31(8-9):633-50. doi: 10.1080/00498250110054632. [PMID: 11569530]
  • F Cools, A Benatar, A Bougatef, Y Vandenplas. The effect of cisapride on the corrected QT interval and QT dispersion in premature infants. Journal of pediatric gastroenterology and nutrition. 2001 Aug; 33(2):178-81. doi: 10.1097/00005176-200108000-00015. [PMID: 11568520]
  • Y Kii, K Nakatsuji, I Nose, M Yabuuchi, Y Mizuki, T Ito. Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats. Pharmacology & toxicology. 2001 Aug; 89(2):96-103. doi: 10.1034/j.1600-0773.2001.d01-142.x. [PMID: 11555327]
  • A Benatar, A Feenstra, T Decraene, Y Vandenplas. Cisapride plasma levels and corrected QT interval in infants undergoing routine polysomnography. Journal of pediatric gastroenterology and nutrition. 2001 Jul; 33(1):41-6. doi: 10.1097/00005176-200107000-00007. [PMID: 11479406]
  • H Itoh, T Nagano, M Takeyama. Cisapride raises the bioavailability of paracetamol by inhibiting its glucuronidation in man. The Journal of pharmacy and pharmacology. 2001 Jul; 53(7):1041-5. doi: 10.1211/0022357011776298. [PMID: 11480539]
  • E M Offman, D J Freeman, G K Dresser, C Munoz, J R Bend, D G Bailey. Red wine-cisapride interaction: comparison with grapefruit juice. Clinical pharmacology and therapeutics. 2001 Jul; 70(1):17-23. doi: 10.1067/mcp.2001.116892. [PMID: 11452240]
  • C Simard, G E O'Hara, J Prévost, R Guilbaud, R Masseé, J Turgeon. Study of the drug-drug interaction between simvastatin and cisapride in man. European journal of clinical pharmacology. 2001 Jun; 57(3):229-34. doi: 10.1007/s002280100298. [PMID: 11497338]
  • G A Gintant, J T Limberis, J S McDermott, C D Wegner, B F Cox. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Journal of cardiovascular pharmacology. 2001 May; 37(5):607-18. doi: 10.1097/00005344-200105000-00012. [PMID: 11336111]
  • R Silang, M Regalado, T H Cheng, D E Wesson. Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2001 Feb; 37(2):287-93. doi: 10.1053/ajkd.2001.21291. [PMID: 11157368]
  • Q Zhao, M A Wojcik, J L Parier, L Pesco-Koplowitz. Influence of coadministration of fluoxetine on cisapride pharmacokinetics and QTc intervals in healthy volunteers. Pharmacotherapy. 2001 Feb; 21(2):149-57. doi: 10.1592/phco.21.2.149.34109. [PMID: 11213850]
  • M Takeda, Y Mizutani, M Yamano, K Tsukamoto, T Suzuki. Gastric emptying in diabetic gastroparetic dogs: ffects of SK-951,a novel prokinetic agent. Pharmacology. 2001 Jan; 62(1):23-28. doi: 10.1159/000056068. [PMID: 11150919]
  • M C de Condado, A Malave, M A Dorantes-Hernandez, A Rathinavelu. Liquid chromatographic method with electrochemical detection for determination of cisapride in serum. Journal of AOAC International. 2001 Jan; 84(1):9-12. doi: 10.1093/jaoac/84.1.9. [PMID: 11234857]
  • H Lefebvre, D Cartier, C Duparc, V Contesse, I Lihrmann, C Delarue, H Vaudry, R Fischmeister, J M Kuhn. Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism. Endocrine research. 2000 Nov; 26(4):583-7. doi: 10.3109/07435800009048575. [PMID: 11196433]
  • H T Lee, Y J Lee, S J Chung, C K Shim. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats. Research communications in molecular pathology and pharmacology. 2000 Nov; 108(5-6):311-23. doi: NULL. [PMID: 11958284]
  • M J Hentges, B W Gunderson, M J Lewis. Retrospective analysis of cisapride-induced QT changes in end-stage renal disease patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2000 Nov; 15(11):1814-8. doi: 10.1093/ndt/15.11.1814. [PMID: 11071970]
  • M K Scott, M A Kim, M A Kraus, B A Mueller, R A Sehra, G T Altemose, K M Sowinski. Effect of cisapride on QT interval in patients with end-stage renal disease. The American journal of cardiology. 2000 Oct; 86(8):873-5. doi: 10.1016/s0002-9149(00)01109-7. [PMID: 11024404]
  • T Mushiroda, R Douya, E Takahara, O Nagata. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug metabolism and disposition: the biological fate of chemicals. 2000 Oct; 28(10):1231-7. doi: . [PMID: 10997945]
  • L E Oufir, J L Barry, B Flourié, C Cherbut, D Cloarec, F Bornet, J P Galmiche. Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria. European journal of clinical nutrition. 2000 Aug; 54(8):603-9. doi: 10.1038/sj.ejcn.1600687. [PMID: 10951507]
  • Z Desta, N V Soukhova, A Morocho, J Park, S K Mahal, D A Flockhart. Stereoselective determination of cisapride, a prokinetic agent, in human plasma by chiral high-performance liquid chromatography with ultraviolet detection: application to pharmacokinetic study. Journal of chromatography. B, Biomedical sciences and applications. 2000 Jul; 744(2):263-72. doi: 10.1016/s0378-4347(00)00247-4. [PMID: 10993514]
  • E L Michalets, C R Williams. Drug interactions with cisapride: clinical implications. Clinical pharmacokinetics. 2000 Jul; 39(1):49-75. doi: 10.2165/00003088-200039010-00004. [PMID: 10926350]
  • H Bohets, K Lavrijsen, J Hendrickx, J van Houdt, V van Genechten, P Verboven, W Meuldermans, J Heykants. Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions. British journal of pharmacology. 2000 Apr; 129(8):1655-67. doi: 10.1038/sj.bjp.0703246. [PMID: 10780971]
  • R MacLaren, D A Kuhl, J M Gervasio, R O Brown, R N Dickerson, T N Livingston, K Swift, S Headley, K A Kudsk, J J Lima. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. Critical care medicine. 2000 Feb; 28(2):438-44. doi: 10.1097/00003246-200002000-00025. [PMID: 10708180]
  • H Kentrup, H J Baisch, G Kusenbach, G Heimann, H Skopnik. Effect of cisapride on acid gastro-oesophageal reflux during treatment with caffeine. Biology of the neonate. 2000 Feb; 77(2):92-5. doi: 10.1159/000014200. [PMID: 10657685]
  • K T Kivistö, J J Lilja, J T Backman, P J Neuvonen. Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride. Clinical pharmacology and therapeutics. 1999 Nov; 66(5):448-53. doi: 10.1016/s0009-9236(99)70007-x. [PMID: 10579471]
  • Y Preechagoon, B Charles, V Piotrovskij, T Donovan, A Van Peer. Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease. British journal of clinical pharmacology. 1999 Nov; 48(5):688-93. doi: 10.1046/j.1365-2125.1999.00068.x. [PMID: 10594470]
  • S Kechagias, K A Jönsson, A W Jones. Impact of gastric emptying on the pharmacokinetics of ethanol as influenced by cisapride. British journal of clinical pharmacology. 1999 Nov; 48(5):728-32. doi: 10.1046/j.1365-2125.1999.00080.x. [PMID: 10594475]
  • Z Zhou, Q Gong, C T January. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects. The Journal of biological chemistry. 1999 Oct; 274(44):31123-6. doi: 10.1074/jbc.274.44.31123. [PMID: 10531299]
  • G M Ferron, J C Paul, R J Fruncillo, P T Martin, L Yacoub, P R Mayer. Lack of pharmacokinetic interaction between oral pantoprazole and cisapride in healthy adults. Journal of clinical pharmacology. 1999 Sep; 39(9):945-50. doi: 10.1177/00912709922008588. [PMID: 10471987]
  • F Cataldo. [Cisapride and risk of cardiac complications]. Minerva pediatrica. 1999 Sep; 51(9-10):309-11. doi: NULL. [PMID: 10783591]
  • M D Drici, S N Ebert, W X Wang, I Rodriguez, X K Liu, B H Whitfield, R L Woosley. Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart. Journal of cardiovascular pharmacology. 1999 Jul; 34(1):82-8. doi: 10.1097/00005344-199907000-00014. [PMID: 10413072]
  • K Mihara, K Otani, N Yasui, M Ishida, T Kondo, A Suzuki, H Furukori, U Nagashima, S Kaneko, Y Inoue. No pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidol. Therapeutic drug monitoring. 1999 Jun; 21(3):297-300. doi: 10.1097/00007691-199906000-00007. [PMID: 10365640]
  • H M Lee, S J Choi, C K Jeong, Y S Kim, K C Lee, H S Lee. Microbore high-performance liquid chromatographic determination of cisapride in rat serum samples using column switching. Journal of chromatography. B, Biomedical sciences and applications. 1999 Apr; 727(1-2):213-7. doi: 10.1016/s0378-4347(99)00103-6. [PMID: 10360440]
  • A S Gross, Y D Goh, R S Addison, G M Shenfield. Influence of grapefruit juice on cisapride pharmacokinetics. Clinical pharmacology and therapeutics. 1999 Apr; 65(4):395-401. doi: 10.1016/s0009-9236(99)70133-5. [PMID: 10223776]
  • R S Addison, S L Duffy, S R Mathers. A simple high-performance liquid chromatography assay for the major cisapride metabolite, norcisapride, in human urine. Journal of chromatographic science. 1999 Mar; 37(3):61-4. doi: 10.1093/chromsci/37.3.61. [PMID: 10089595]
  • R M Ward, J A Lemons, R A Molteni. Cisapride: a survey of the frequency of use and adverse events in premature newborns. Pediatrics. 1999 Feb; 103(2):469-72. doi: 10.1542/peds.103.2.469. [PMID: 9925843]
  • C M Steel, J R Bolton, Y Preechagoon, B G Charles. Pharmacokinetics of cisapride in the horse. Journal of veterinary pharmacology and therapeutics. 1998 Dec; 21(6):433-6. doi: 10.1046/j.1365-2885.1998.00168.x. [PMID: 9885965]
  • A D van Haarst, G A van 't Klooster, J M van Gerven, R C Schoemaker, J C van Oene, J Burggraaf, M C Coene, A F Cohen. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clinical pharmacology and therapeutics. 1998 Nov; 64(5):542-6. doi: 10.1016/s0009-9236(98)90137-0. [PMID: 9834046]
  • J Vitola, J Vukanovic, D M Roden. Cisapride-induced torsades de pointes. Journal of cardiovascular electrophysiology. 1998 Oct; 9(10):1109-13. doi: 10.1111/j.1540-8167.1998.tb00888.x. [PMID: 9817562]
  • S Cisternino, J Schlatter, J L Saulnier. Determination of cisapride and norcisapride in human plasma using high-performance liquid chromatography with ultraviolet detection. Journal of chromatography. B, Biomedical sciences and applications. 1998 Sep; 714(2):395-8. doi: 10.1016/s0378-4347(98)00213-8. [PMID: 9766883]
  • A Sugiyama, K Hashimoto. Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring. Toxicology and applied pharmacology. 1998 Sep; 152(1):261-9. doi: 10.1006/taap.1998.8494. [PMID: 9772221]
  • N Haga, H Suzuki, Y Shiba, E Mochiki, A Mizumoto, Z Itoh. Effect of TKS159, a novel 5-hydroxytryptamine4 agonist, on gastric contractile activity in conscious dogs. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 1998 Aug; 10(4):295-303. doi: 10.1046/j.1365-2982.1998.00109.x. [PMID: 9697104]
  • T Yamamoto, K Takano, M Sanaka, Y Kuyama, M Yamanaka, Y Koike, S Mineshita. Pharmacokinetic characteristics of cisapride in elderly patients. International journal of clinical pharmacology and therapeutics. 1998 Aug; 36(8):432-4. doi: NULL. [PMID: 9726696]
  • H Lefebvre, K N Gonzalez, V Contesse, C Delarue, H Vaudry, J M Kuhnl. Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers. Endocrine research. 1998 Aug; 24(3-4):749-52. doi: 10.3109/07435809809032681. [PMID: 9888571]
  • M T Maya, C R Domingos, M T Guerreiro, A P Filipe, J A Morais. Comparative bioavailability of two immediate release tablets of cisapride in healthy volunteers. European journal of drug metabolism and pharmacokinetics. 1998 Jul; 23(3):377-81. doi: 10.1007/bf03192297. [PMID: 9842980]
  • N Valk, T J Doherty, J T Blackford, T W Abraha, D L Frazier. Effect of cisapride on gastric emptying in horses following endotoxin treatment. Equine veterinary journal. 1998 Jul; 30(4):344-8. doi: 10.1111/j.2042-3306.1998.tb04108.x. [PMID: 9705119]
  • S L Hill, J K Evangelista, A M Pizzi, M Mobassaleh, D R Fulton, C I Berul. Proarrhythmia associated with cisapride in children. Pediatrics. 1998 Jun; 101(6):1053-6. doi: 10.1542/peds.101.6.1053. [PMID: 9606235]